News Archive
23 Dec 2013
Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM)
25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
18 Nov 2013
Cytos Biotechnology Ltd: Rights offering oversubscribed - CHF 24.3 million raised
25 Oct 2013
Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules
7 Oct 2013
Personalis Closes $22M Series B Financing
23 Sep 2013
Ablynx and Abbvie Sign Global License Agreement for Anti-IL-6R Nanobody, ALX-0061, to Treat Inflammatory Diseases
17 Sep 2013
Personalis Establishes UK Subsidiary and Appoints Mark Dronsfield as Director of European Sales
4 Sep 2013
Supernus Launches Trokendi XR™ in the United States
26 Aug 2013
Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors
1 Aug 2013
Dicerna Secures $60 Million in Oversubscribed Series C Financing
20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
8 Apr 2013
GenSight Biologics Raises €32m in a Series A Financing
5 Mar 2013
Avedro Completes $43 Million Series D Financing
20 Feb 2013
Gynesonics Completes $21 Million Series D Financing
18 Feb 2013
Roche and Chiasma announce collaboration to develop and commercialize Chiasma's Octreolin®
28 Jan 2013
Avillion LLP receives initial funding from Abingworth and Clarus

 

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
News Archive
23 Dec 2013
Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM)
25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
18 Nov 2013
Cytos Biotechnology Ltd: Rights offering oversubscribed - CHF 24.3 million raised
25 Oct 2013
Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extended-Release Capsules
7 Oct 2013
Personalis Closes $22M Series B Financing
23 Sep 2013
Ablynx and Abbvie Sign Global License Agreement for Anti-IL-6R Nanobody, ALX-0061, to Treat Inflammatory Diseases
17 Sep 2013
Personalis Establishes UK Subsidiary and Appoints Mark Dronsfield as Director of European Sales
4 Sep 2013
Supernus Launches Trokendi XR™ in the United States
26 Aug 2013
Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors
1 Aug 2013
Dicerna Secures $60 Million in Oversubscribed Series C Financing
20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
8 Apr 2013
GenSight Biologics Raises €32m in a Series A Financing
5 Mar 2013
Avedro Completes $43 Million Series D Financing
20 Feb 2013
Gynesonics Completes $21 Million Series D Financing
18 Feb 2013
Roche and Chiasma announce collaboration to develop and commercialize Chiasma's Octreolin®
28 Jan 2013
Avillion LLP receives initial funding from Abingworth and Clarus
 
Copyright Abingworth 2017